Publications
122
Citations
3,107
Est. group size
—
Recurring co-author estimate
Active years
28
Publishing since 1999
Arjun Sinha studies heart failure and cardiovascular disease, examining who is at risk and why, using large population studies, electronic health records, and molecular tools like single-cell analysis of heart tissue. Recent work also explores the heart-related side effects of cancer therapies (such as CAR T-cell treatments), links between inflammation, immune cells, and heart disease, and the intersection of kidney disease and heart function. The research spans both clinical outcomes and underlying biological mechanisms.
Publication output rose to a peak around 2020-2021 and has been lower and relatively steady since, averaging about 4-5 papers per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Single-Cell Splicing Isoform Atlas of the Adult Human Heart and Heart Failure
Circulation · 2025
- Barriers and Opportunities in Access to Peritoneal Dialysis across Veterans Health Administration
Clinical Journal of the American Society of Nephrology · 2025
- Serum Metabolites and Heart Failure Risk: MESA and RS
Journal of the American Heart Association · 2025
- Designing target trials using electronic health records: A case study of second-line disease-modifying anti-rheumatic drugs and cardiovascular disease outcomes in patients with rheumatoid arthritis
PLoS ONE · 2024
- Association Between Cardiovascular Health and Lifetime Risk of Heart Failure
JACC Heart Failure · 2024
- TIMELINE OF THE DEVELOPMENT OF CARDIOVASCULAR ADVERSE EVENTS FOLLOWING TREATMENT WITH CHIMERIC ANTIGEN RECEPTOR T CELL THERAPIES
Journal of the American College of Cardiology · 2024
- GLOBAL LONGITUDINAL STRAIN IS ASSOCIATED WITH CARDIOVASCULAR ADVERSE EVENTS IN DIFFUSE LARGE B CELL LYMPHOMA PATIENTS RECEIVING CHIMERIC ANTIGEN RECEPTOR T CELL THERAPIES
Journal of the American College of Cardiology · 2024
- Single-cell profiling reveals inflammatory polarization of human carotid versus femoral plaque leukocytes
JCI Insight · 2023
- Myocardial strain is associated with adverse cardiac events in patients treated with chimeric antigen receptor (<scp>CAR</scp>) T‐cell therapy
European Journal Of Haematology · 2023
- Don’t judge a book by its cover: a case report of apolipoprotein A-IV cardiac amyloidosis
European Heart Journal - Case Reports · 2023
- Hypertrophic Cardiomyopathy Secondary to <i>RAF1</i> Cysteine-Rich Domain Variants
Circulation Genomic and Precision Medicine · 2023
- Response: Letter to the Editor
Journal of Cardiac Failure · 2023
- Interconnected Clinical and Social Risk Factors in Breast Cancer and Heart Failure
Frontiers in Cardiovascular Medicine · 2022
- Association of Immune Cell Subsets with Incident Heart Failure in Two Population-Based Cohorts
ESC Heart Failure · 2022
- Monocyte subsets, T cell activation profiles, and stroke in men and women: The Multi-Ethnic Study of Atherosclerosis and Cardiovascular Health Study
Atherosclerosis · 2022
- Circulation×14
- Journal of the American Heart Association×5
- Journal of the American College of Cardiology×5
- PMC×4
- Clinical Journal of the American Society of Nephrology×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile